HB 1850
In CommitteeHouse
Glucose monitor replacement
Facilitating the prompt replacement of defective continuous glucose monitoring equipment.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires pharmacies—both in-person and mail-order—to keep enough continuous glucose monitor sensors available to replace defective or emergency-use sensors quickly. For retail pharmacies, replacements must be provided the same day; for mail-order, replacements must be shipped by the next business day.
- Retail pharmacies must keep enough continuous glucose monitoring (CGM) sensors on hand to provide a same-day replacement if a patient has a malfunction or emergency.
- Mail-order pharmacies must send a replacement sensor by the next business day (or as soon as practicable if mailing then is not possible) for patients with malfunctions or emergencies.
- The requirement applies only when a malfunction or emergency means the patient needs an extra sensor, not for routine refills.
- The law adds a new section to chapter 18.64 RCW, which governs pharmacy practices in Washington.
Who is affected
- Patients using continuous glucose monitors — People with diabetes who use continuous glucose monitors (CGMs) and may experience device malfunctions or emergencies requiring urgent sensor replacement.
- Retail pharmacies — Pharmacies that dispense CGM sensors in person must keep extra sensors on hand for same-day replacements when needed.
- Mail-order pharmacies — Mail-order pharmacies must ensure replacement sensors are shipped quickly—ideally the next business day—if a patient needs one due to a malfunction or emergency.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (3)
Patients with diabetes who rely on CGMs will experience reduced risk of dangerous hypoglycemic or hyperglycemic events during device malfunctions, improving health outcomes and potentially reducing emergency department visits and hospitalizations.
HealthcarePeopleRef: Sec. 1(1), (2)Timely access to replacement sensors mitigates safety risks associated with interrupted glucose monitoring—such as falls, seizures, or loss of consciousness—especially for vulnerable populations like children, elderly, and those with hypoglycemia unawareness.
Public SafetyPeopleRef: Sec. 1(1), (2)The bill addresses a critical gap in diabetes care continuity: unlike routine refills, malfunction/emergency replacements are not currently guaranteed, and delays can lead to treatment interruption; this standardizes equitable access across retail and mail-order channels.
HealthcarePeopleRef: Sec. 1(1), (2)
Potential Concerns (3)
The requirement to maintain extra inventory of CGM sensors may increase operational costs for pharmacies—particularly small, independent retailers—due to holding non-rotating stock, potentially leading to higher dispensing fees or reduced service quality in low-volume locations.
HealthcarePeopleRef: Sec. 1(1), (2)Pharmacies may face staffing and logistics burdens to fulfill same-day or next-business-day replacement obligations, especially during peak demand or supply chain disruptions, which could strain workforce capacity and increase labor costs.
Business & EmploymentPeopleRef: Sec. 1(1), (2)The state may need to allocate enforcement resources to monitor compliance, though the bill does not specify penalties or a dedicated enforcement mechanism, making this a modest administrative burden.
Local GovernmentLean peopleRef: Sec. 1(1), (2)
Who Is Most Affected
Patients with diabetes who use CGMs—especially those with type 1 diabetes—will directly benefit from reduced health risks and improved treatment continuity during device failures. This population is disproportionately low-income, elderly, or on public insurance (e.g., Medicaid), making timely access life-sustaining.
Retail pharmacies—particularly small, independent ones—may face added inventory and labor costs, but the requirement applies only to malfunctions/emergencies (not routine refills), limiting scope. Chain pharmacies with robust logistics may absorb costs more easily, while rural or under-resourced pharmacies could struggle.
Mail-order pharmacies will need to adjust fulfillment workflows to meet the next-business-day standard, which may require system upgrades or staffing changes. However, they already operate on high-volume models and may integrate this into existing emergency protocols with minimal disruption.